Breaking News Instant updates and real-time market news.

WMT

Walmart

$111.36

5.11 (4.81%)

14:57
08/15/19
08/15
14:57
08/15/19
14:57

Walmart upgraded to Buy from Accumulate at Gordon Haskett

  • 15

    Aug

  • 15

    Sep

  • 25

    Sep

  • 13

    Nov

WMT Walmart
$111.36

5.11 (4.81%)

07/23/19
LOOP
07/23/19
NO CHANGE
Target $115
LOOP
Hold
Walmart price target raised to $115 from $106 at Loop Capital
Loop Capital analyst Andrew Wolf raised his price target on Walmart to $115, saying the company's recently announced consolidation of the U.S. stores and e-commerce divisions' supply chains and financial management is positive for its continued expansion in omnichannel merchandising. The analyst notes that the perception of this consolidation as a sign of "retrenchment and/or infighting at the senior operating ranks" is mistaken. Wolf is keeping his Hold rating on Walmart however, citing its current valuation.
08/12/19
BARD
08/12/19
NO CHANGE
Target $115
BARD
Outperform
Baird comfortable with Walmart expectations ahead of Q2 results
Baird analyst Peter Benedict said he remains comfortable with Q2 Walmart expectations ahead of its report on Thursday. The analyst believes comp trends will remain solid and although he expects pressure on margins from Flipkart, he sees the company continuing to manage and drive SG&A efficiencies. Benedict reiterated his Outperform rating and $115 price target on Walmart shares.
08/15/19
BOFA
08/15/19
NO CHANGE
Target $120
BOFA
Buy
Walmart Q2 results 'impressive' given tough comparison, says BofA/Merrill
BofA Merrill Lynch analyst Robert Ohmes noted that Walmart U.S. faced its toughest comparison of FY20 in Q2 given that U.S. same-store sales grew 4.5% in the same quarter of last year. Given that tough comparison, he views the U.S. same-store sales growth of 2.8% "impressive," Ohmes stated in a post-earnings research note. Walmart's raised full-year adjusted EPS guidance implies $4.83-$4.85, versus the consensus estimate of $4.84, said Ohmes. He reiterated a Buy rating on Walmart shares with a $120 price target, stating that he expects U.S. momentum to continue, fueled by the company investing in its stores, people and "omni-channel transformation."
08/15/19
BARD
08/15/19
NO CHANGE
Target $120
BARD
Outperform
Baird boosts Walmart price target to $120 from $115 after 'solid' Q2
Baird analyst Peter Benedict raised his price target for Walmart to $120 from $115 saying the company's "solid" Q2 results reinforced his positive thesis. The analyst keeps an Outperform rating on the shares. The Q2 results were encouraging, with "solid" U.S. sales and strong expense management fueling a 4% earnings beat, Benedict tells investors in a research note. He believes Walmart's business is "strong" and that its "sophisticated" omni-channel strategy is becoming increasingly difficult to match. As such, the analyst thinks Walmart shares can maintain their "premium valuation metrics."

TODAY'S FREE FLY STORIES

CBRL

Cracker Barrel

$167.79

2.84 (1.72%)

08:05
09/18/19
09/18
08:05
09/18/19
08:05
Recommendations
Cracker Barrel analyst commentary  »

Cracker Barrel price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANW

S&W Seed

$2.33

-0.03 (-1.27%)

08:05
09/18/19
09/18
08:05
09/18/19
08:05
Earnings
S&W Seed sees FY20 core revenue $41M-$44M, consensus $54.57M »

Including contributions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

SCPH

scPharmaceuticals

$7.07

0.07 (1.00%)

08:05
09/18/19
09/18
08:05
09/18/19
08:05
Hot Stocks
scPharmaceuticals plans to resubmit FUROSCIX NDA by mid-year 2020 »

scPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRIO

DarioHealth

$0.37

-0.0201 (-5.14%)

08:04
09/18/19
09/18
08:04
09/18/19
08:04
Hot Stocks
DarioHealth awarded new U.S. patent »

DarioHealth announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CVGI

Commercial Vehicle Group

$7.18

0.08 (1.13%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Hot Stocks
Commercial Vehicle Group acquires First Source Electronics for $44.75M »

Commercial Vehicle Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BE

Bloom Energy

$3.30

-0.89 (-21.24%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Recommendations
Bloom Energy analyst commentary  »

Morgan Stanley stays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANW

S&W Seed

$2.33

-0.03 (-1.27%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Earnings
S&W Seed reports Q4 non-GAAP EPS 50c, consensus $1.05 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

AZO

AutoZone

$1,156.07

26.56 (2.35%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Recommendations
AutoZone analyst commentary  »

AutoZone price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ALL

Allstate

$107.94

1.56 (1.47%)

08:01
09/18/19
09/18
08:01
09/18/19
08:01
Conference/Events
Executives Club of Chicago to hold a breakfast meeting »

Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 30

    Oct

CPRI

Capri Holdings

$31.68

-0.58 (-1.80%)

08:00
09/18/19
09/18
08:00
09/18/19
08:00
Recommendations
Capri Holdings analyst commentary  »

Capri Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCR

NCR Corp.

$32.85

-0.26 (-0.79%)

07:59
09/18/19
09/18
07:59
09/18/19
07:59
Initiation
NCR Corp. initiated  »

NCR Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ALNA

Allena Pharmaceuticals

$4.20

-0.035 (-0.83%)

07:55
09/18/19
09/18
07:55
09/18/19
07:55
Conference/Events
Allena Pharmaceuticals to hold a KOL breakfast meeting »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

  • 24

    Sep

AAPL

Apple

$220.77

0.89 (0.40%)

07:52
09/18/19
09/18
07:52
09/18/19
07:52
Recommendations
Apple analyst commentary  »

Apple iPhone launch could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$4.79

0.09 (1.91%)

07:52
09/18/19
09/18
07:52
09/18/19
07:52
Hot Stocks
Avon Products announces launch of new skincare and make-up brand 'Distillery' »

Avon Products announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$45.15

0.55 (1.23%)

, AMD

AMD

$31.00

0.17 (0.55%)

07:51
09/18/19
09/18
07:51
09/18/19
07:51
Periodicals
TSMC extends production lead time for 7nm chip capacity, DIgiTimes reports »

TSMC (TSM) is extending…

TSM

TSMC

$45.15

0.55 (1.23%)

AMD

AMD

$31.00

0.17 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

CBRL

Cracker Barrel

$167.79

2.84 (1.72%)

07:50
09/18/19
09/18
07:50
09/18/19
07:50
Recommendations
Cracker Barrel analyst commentary  »

Cracker Barrel price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:50
09/18/19
09/18
07:50
09/18/19
07:50
General news
U.S. MBA reported mortgage applications dipped -0.1% in the September 13 week »

U.S. MBA reported…

AKTS

Akoustis

$7.90

0.1 (1.28%)

07:48
09/18/19
09/18
07:48
09/18/19
07:48
Downgrade
Akoustis rating change  »

Northland downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 12

    Nov

ACHV

Achieve Life Sciences

$2.23

-0.03 (-1.33%)

07:46
09/18/19
09/18
07:46
09/18/19
07:46
Conference/Events
Achieve Life Sciences to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

CBWTF

Auxly Cannabis

$0.00

(0.00%)

07:45
09/18/19
09/18
07:45
09/18/19
07:45
Hot Stocks
Auxly Cannabis announces Canadian brokerage agreement with Kindred Partners »

Auxly Cannabis Group and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IOTS

Adesto Technologies

$10.63

-0.66 (-5.85%)

07:45
09/18/19
09/18
07:45
09/18/19
07:45
Initiation
Adesto Technologies initiated  »

Adesto Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCE

Spark Therapeutics

$104.41

-0.41 (-0.39%)

07:43
09/18/19
09/18
07:43
09/18/19
07:43
Hot Stocks
Spark Therapeutics, paralympic skier partner for genetic testing awareness »

Spark Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KLAC

KLA-Tencor

$152.55

1.38 (0.91%)

07:42
09/18/19
09/18
07:42
09/18/19
07:42
Recommendations
KLA-Tencor analyst commentary  »

KLA-Tencor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$1.73

-0.045 (-2.54%)

07:40
09/18/19
09/18
07:40
09/18/19
07:40
Hot Stocks
vTv Therapeutics presents additional data from Phase 2 Simplici-T1 study »

vTv Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

07:40
09/18/19
09/18
07:40
09/18/19
07:40
General news
Treasury Market Outlook: yields extended declines overnight »

Treasury Market Outlook:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.